Do you want to change careers? Are you absolutely sure?
From my own career change to the stories I hear from my clients and workshop students, often we think we want to change careers when the problem is our work environment instead. If you find yourself stuck, unsure what to do next, or t
NCC Limited (NCC) is one of the largest well diversified construction companies in India with having a foothold in every segment of construction sector. FY18 Order book grew by 80% YoY (4.3x TTM revenue) stimulated by 174% YoY rise in fresh orders. Q4FY18 revenue grew by 12% (below estimate), due to 11% decline in road project execution. EBITDA margin....More>>>
Starbucks Corporation (NASDAQ:SBUX) has always been a tough one for me. On the one hand, the company has been a great performer over the long-term, but it’s been stuck in a multi-year lull.
In a way, it sort of reminds me of Walt Disney Co (NYSE:DIS). I touched on this fact a few weeks ago with Disney, in that it was disappointing for recent investors but over the last five years or....More>>>
Caisse DE Depot ET Placement DU Quebec raised its position in ConocoPhillips (NYSE:COP) by 285.9% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 652,900 shares of the energy producer’s stock after purchasing an additional 483,700 shares during the quarter. Caisse DE Depot ET Placement DU Quebec owned 0.06% of ConocoPhillips....More>>>
S&P Global Market Intelligence’s Jeffrey Loo explains why he’s maintaining his Buy rating on Valeant Pharmaceuticals International (VRX) following reports it had rejected a takeover bid earlier this year:
According to unconfirmed reports, including the Wall Street Journal,Valeant rejected an unsolicited joint takeover bid from Takeda Pharmaceutical, the largest....More>>>
Energy investors are making a big mistake… They're "bottom fishing" in the major oil and gas stocks… trying to catch the bottom. This, of course, is a bad idea. Energy stocks have been crashing this year. But expectations are still high. History tells us this kind of bottom fishing won't end well. The smart move is to wait for a better entry point....More>>>
Growth versus value investing is one of the major debates in the investment world. Growth stocks seem to have outperformed their value counterparts over the past few years. But the winning streak of growth investing took a hit this year with value stocks regaining lost glory.
It is currently speculated that value investing will likely continue its winning run in the upcoming years.....More>>>
Westpac Banking Corp raised its stake in Edwards Lifesciences (NYSE:EW) by 22.6% in the 1st quarter, according to its most recent filing with the SEC. The fund owned 67,689 shares of the medical research company’s stock after purchasing an additional 12,500 shares during the period. Westpac Banking Corp’s holdings in Edwards Lifesciences were worth $9,444,000 as of its most recent SEC....More>>>
The biopharma and drug supply chain sectors outperformed the market last week, even as Trump administration officials pressed the president's blueprint to lower drug prices, with tough rhetoric for drugmakers and public shaming of pharmaceutical firms for supposedly blocking competition.
Since March 2009, the stock market has been virtually unstoppable. At one point in January 2018, all three major indexes -- the Dow Jones Industrial Average, S&P 500, and Nasdaq-- had essentially quadrupled from their Great Recession lows.
NanoString Technologies (NASDAQ: NSTG) is one of 91 publicly-traded companies in the “Biological products, except diagnostic” industry, but how does it contrast to its competitors? We will compare NanoString Technologies to related businesses based on the strength of its earnings, p
Geron Corporation (NASDAQ:GERN), a clinical-stage cancer company, has grabbed the attention of growth investors due to its enormous upside potential. The short version of the story is that Geron is awaiting a critical continuation decision by partner Johnson & Johnson (NYSE:JNJ) in regards t
The average stock in the Nasdaq 100 is up just over 3% year to date. Using snapshots from our popular Trend Analyzer tool, below is a look at the best and worst performing stocks in the Nasdaq 100 so far in 2018.
At the top of the list is Netflix (NASDAQ:NFLX) with a year-to-date gain of